US FDA Mulls Pilot To Examine Separate Review Pathway For Novel Excipients

 
• By Joanne S. Eglovitch

Proposal could yield a bounty of new options for innovative drug delivery systems.

assortment of pills and capsules of colors in plastic jars isolated in white - Image
FDA Poring Over Possibility Of Separate Reviews For Novel Excipients • Source: Shutterstock

More from Manufacturing

More from Compliance